Editorial team
ioQuanta Research Desk
-
Evidence date ·Why can more tiny cellulose make rubber weaker?
Review or Meta-AnalysisA 2021 review shows how nanocellulose can strengthen some rubber mixtures, while clumping and reduced stretch complicate partial replacement of conventional fillers.
-
Evidence date ·Who was the afatinib study about, and what counted as a response?
Clinical TrialPhysicians' charts and tumor measurements offer two ways to count response in this afatinib study. Its broad title and lung cancer listing leave the patient mix unclear.
-
Evidence date ·When do ground olive stones help plastic, and when do they hurt?
Review or Meta-AnalysisA reviewed polypropylene composite was 18% stiffer with 40% olive-pit filler, but its impact strength fell about 82.5%. The review also examines non-structural panels.
-
Evidence date ·How added particles turn flexible plastic into a radiation shield
Review or Meta-AnalysisA lighter tungsten-filled polyethylene sheet had X-ray absorption comparable to lead in a cited study. The review explains why neutrons need different materials.
-
Evidence date ·What bending does to a battery electrode
Review or Meta-AnalysisThe metal-supported group had higher average initial capacity in a 2021 review, while carbon-based designs appeared steadier over cycling; test conditions varied.
-
Evidence date ·Why sensor setup matters for inspection waves in plates and pipes
Review or Meta-AnalysisA 2021 review groups five sensor types and examines arrangements for sending and receiving sideways waves in plates and pipes.
-
Evidence date ·What lets some tumor-fighting T cells sustain a response?
Review or Meta-AnalysisCheckpoint drugs rely in part on a lasting supply of tumor-fighting T cells. A 2021 review explains why cell state and tumor access matter.
-
Evidence date ·What can a tumor response tell someone with advanced cancer of the upper urinary tract?
Review or Meta-AnalysisA 2021 review found a 21.2% tumor response rate with immunotherapy in upper urinary tract cancer; it did not establish a survival benefit over platinum chemotherapy.
-
Evidence date ·How a mouse model tracked melanoma after T cells lost control
Peer-Reviewed PaperPatient-derived T cells slowed engineered melanoma tumors in mice, but growth resumed. Repeating the transfer or blocking PD-1 improved later control.
-
Evidence date ·Can releasing T-cell brakes help when COVID-19 inflames the lungs?
Review or Meta-AnalysisA February 2021 review asks whether cancer drugs that block PD-1 could restore antiviral T-cell activity in severe COVID-19, and examines lung risks and trial plans.